<table id="table8" width="80%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 8 Drug Interactions:  Changes in Pharmacokinetic Parameters for Coadministered Drug in the Presence of Tenofovir Disoproxil Fumarate<footnote>All interaction studies conducted in healthy volunteers.</footnote>
<sup>,</sup>
<footnote>Subjects received tenofovir DF 300 mg once daily.</footnote>
</caption>
<col align="left" valign="middle" width="18%"></col>
<col align="center" valign="middle" width="18%"></col>
<col align="center" valign="middle" width="10%"></col>
<col align="center" valign="middle" width="18%"></col>
<col align="center" valign="middle" width="18%"></col>
<col align="center" valign="middle" width="18%"></col>
<thead>
<tr>
<th align="center" rowspan="2" stylecode="Lrule Rrule">Coadministered Drug</th>
<th rowspan="2" stylecode="Rrule">Dose of Coadministered Drug (mg)</th>
<th rowspan="2" stylecode="Rrule">N</th>
<th colspan="3" stylecode="Rrule Botrule">Mean % Change of Coadministered Drug Pharmacokinetic Parameters<footnote>Increase = ↑; Decrease = ↓; No Effect = ↔</footnote>
<br/>  (90% CI)</th>
</tr>
<tr stylecode="Botrule">
<th align="center" stylecode="Rrule">C<sub>max</sub>
</th>
<th stylecode="Rrule">AUC</th>
<th stylecode="Rrule">C<sub>min</sub>
</th>
</tr>
</thead>
<tbody>
<tr>
<td stylecode="Lrule Rrule">Atazanavir<footnote>Reyataz Prescribing Information</footnote>
</td>
<td stylecode="Rrule Botrule">400 once daily<br/> × 14 days</td>
<td stylecode="Rrule Botrule">34</td>
<td stylecode="Rrule Botrule">↓ 21<br/>  (↓ 27 to ↓ 14)</td>
<td stylecode="Rrule Botrule">↓ 25<br/>  (↓ 30 to ↓ 19)</td>
<td stylecode="Rrule Botrule">↓ 40<br/>  (↓ 48 to ↓ 32)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule"></td>
<td stylecode="Rrule">Atazanavir/ritonavir<br/> 300/100 once daily<br/> × 42 days</td>
<td stylecode="Rrule">10</td>
<td stylecode="Rrule">↓ 28<br/>  (↓ 50 to ↑ 5)</td>
<td stylecode="Rrule">↓ 25<footnote id="t8fte">In HIV-infected patients, addition of tenofovir DF to atazanavir 300 mg plus ritonavir 100 mg, resulted in AUC and C<sub>min</sub> values of atazanavir that were 2.3- and 4-fold higher than the respective values observed for atazanavir 400 mg when given alone.</footnote>
<br/>  (↓ 42 to ↓ 3)</td>
<td stylecode="Rrule">↓ 23<footnoteref idref="t8fte"></footnoteref>
<br/>  (↓ 46 to ↑ 10)</td>
</tr>
<tr stylecode="Botrule">
<td stylecode="Lrule Rrule">Lopinavir</td>
<td stylecode="Rrule">Lopinavir/ritonavir 400/100 twice daily × 14 days</td>
<td stylecode="Rrule">24</td>
<td stylecode="Rrule">																↔ 															</td>
<td stylecode="Rrule">																↔ 															</td>
<td stylecode="Rrule">																↔ 															</td>
</tr>
<tr>
<td stylecode="Lrule Rrule">Ritonavir</td>
<td stylecode="Rrule">Lopinavir/ritonavir 400/100 twice daily × 14 days</td>
<td stylecode="Rrule">24</td>
<td stylecode="Rrule">																↔ 															</td>
<td stylecode="Rrule">																↔ 															</td>
<td stylecode="Rrule">																↔ 															</td>
</tr>
</tbody>
</table>